Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Market Closed -
OTC Markets
22:27:10 10/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | - |
| 02/02/16 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 09/07/15 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.83M 1.7M 1.56M 2.94M 203M 2.99M 20.11M 7.88M 102M 7.99M 7.82M 337M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.78M 5.4M 4.96M 9.32M 645M 9.47M 63.73M 24.96M 323M 25.32M 24.77M 1.07B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 6 months | -50.00% |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.03 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 01/04/2015 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 16/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 29/05/1991 |
Sidney Emery
BRD | Director/Board Member | 76 | 03/10/2005 |
| Director/Board Member | 59 | 06/08/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | 0.00% | 2.13K | ||
| -4.79% | +3.05% | -15.81% | +24.43% | 3.41B | ||
| -0.94% | +6.49% | +37.80% | +1,346.28% | 2.99B | ||
| -4.27% | -4.45% | +23.05% | +409.09% | 2.4B | ||
| -1.99% | -2.09% | -32.90% | -17.89% | 1.76B | ||
| +2.45% | +2.94% | +165.82% | +577.42% | 1.38B | ||
| +0.55% | -6.04% | +10.09% | +22.86% | 613M | ||
| +2.38% | +4.37% | +17.10% | +29.21% | 321M | ||
| +2.62% | -6.16% | +44.97% | +67.07% | 188M | ||
| +1.45% | +3.70% | +42.86% | +86.67% | 120M | ||
| Average | -0.20% | -1.70% | +29.30% | +254.51% | 1.32B | |
| Weighted average by Cap. | -2.06% | -1.63% | +23.55% | +448.15% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.14M 13.2M 12.11M 22.78M 1.58B 23.16M 156M 61.01M 790M 61.89M 60.55M 2.61B | 14.01M 12.02M 11.22M 10.3M 19.36M 1.34B 19.68M 132M 51.86M 672M 52.61M 51.47M 2.22B |
| Net income | -4.29M -3.68M -3.44M -3.15M -5.93M -410M -6.03M -40.57M -15.88M -206M -16.12M -15.76M -680M | -7.61M -6.53M -6.09M -5.59M -10.51M -727M -10.69M -71.91M -28.16M -365M -28.57M -27.94M -1.21B |
| Net Debt | 3.04M 2.61M 2.44M 2.24M 4.21M 291M 4.27M 28.76M 11.26M 146M 11.43M 11.18M 482M | 4.62M 3.96M 3.7M 3.39M 6.38M 441M 6.48M 43.62M 17.08M 221M 17.33M 16.95M 731M |
Employees
61
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















